A First-in-Human, Phase 1 Study of SY-4798 in Patients With Advanced Solid Tumor

NCT05498519 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
80
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Shouyao Holdings (Beijing) Co. LTD